Continuous Kidney Replacement Therapy–Induced Hypophosphatemia: A Nuisance or a Clinically Meaningful Target?
American Journal of Kidney Diseases · 2026-05 · 87 (5) · 615-617
DOI: 10.1053/j.ajkd.2026.03.032 ↗Kurz gefasst
Editorial in der Zeitschrift American Journal of Kidney Diseases, 2026-05. Verfasst von J Pedro Teixeira. Beteiligte Einrichtung: Divisions of Nephrology and Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of New Mexico School of Medicin…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Divisions of Nephrology and Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico. Electronic address: jteixeira@salud.unm.ed…
Zitieren
APA
Teixeira, J. P. (2026). Continuous Kidney Replacement Therapy–Induced Hypophosphatemia: A Nuisance or a Clinically Meaningful Target?. American Journal of Kidney Diseases, 87(5), 615-617. https://doi.org/10.1053/j.ajkd.2026.03.032
Vancouver
Teixeira JP. Continuous Kidney Replacement Therapy–Induced Hypophosphatemia: A Nuisance or a Clinically Meaningful Target?. American Journal of Kidney Diseases. 2026;87(5):615-617. doi:10.1053/j.ajkd.2026.03.032
BibTeX
@article{Teixeira2026,
author = {Teixeira, J Pedro},
title = {Continuous Kidney Replacement Therapy–Induced Hypophosphatemia: A Nuisance or a Clinically Meaningful Target?},
journal = {American Journal of Kidney Diseases},
year = {2026},
volume = {87},
number = {5},
pages = {615--617},
doi = {10.1053/j.ajkd.2026.03.032}
}
EUVIMED